111 related articles for article (PubMed ID: 7605086)
1. Comparison of the usefulness of serum CA 125 level and a risk scoring system in detecting malignancy in ovarian cysts.
Tay SK
Ann Acad Med Singap; 1995 Jan; 24(1):168-71. PubMed ID: 7605086
[TBL] [Abstract][Full Text] [Related]
2. Differential diagnosis of peri- and postmenopausal ovarian cysts.
Reimer T; Gerber B; Müller H; Jeschke U; Krause A; Friese K
Maturitas; 1999 Jan; 31(2):123-32. PubMed ID: 10227005
[TBL] [Abstract][Full Text] [Related]
3. [Usefulness of clinical evaluation for the level of CA-125 antigen and ultrasonographic color Doppler examination in diagnosis of ovarian tumor].
Czekierdowski A; Zrubek H; Sikorski M; Wiktor H; Józefczak M; Stachowicz N
Ginekol Pol; 1996 Nov; 67(11):552-6. PubMed ID: 9289441
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor (VEGF) improves the sensitivity of CA125 for differentiation of epithelial ovarian cancers from ovarian cysts.
Robati M; Ghaderi A; Mehraban M; Shafizad A; Nasrolahi H; Mohammadianpanah M
Arch Gynecol Obstet; 2013 Oct; 288(4):859-65. PubMed ID: 23564055
[TBL] [Abstract][Full Text] [Related]
5. [Prospective study of the correlation of ultrasonography and CA125 in the management of ovarian cysts: a study of 77 cases].
Mathlouthi N; Ben Ayed B; Dhouib M; Chaabene K; Trabelsi K; Amouri H; Guermazi M
Tunis Med; 2011; 89(8-9):686-92. PubMed ID: 21948683
[TBL] [Abstract][Full Text] [Related]
6. Serum LDH and CA-125: Markers for Diagnosis of Ovarian Malignancy.
Deeba F; Khatun S; Alam MM; Shahida SM
Mymensingh Med J; 2015 Apr; 24(2):334-40. PubMed ID: 26007262
[TBL] [Abstract][Full Text] [Related]
7. [The estimation of the probability of tumor malignacy on the basis of test combination in the primary diagnosis of adnexal tumors].
Smoleń A; Stachowicz N; Czekierowski A; Kotarski J
Ginekol Pol; 2010 Apr; 81(4):254-61. PubMed ID: 20476596
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings and menopausal status in the pre-operative diagnosis of pelvic masses.
Tingulstad S; Hagen B; Skjeldestad FE; Onsrud M; Kiserud T; Halvorsen T; Nustad K
Br J Obstet Gynaecol; 1996 Aug; 103(8):826-31. PubMed ID: 8760716
[TBL] [Abstract][Full Text] [Related]
9. Comparison of risk of malignancy indices in evaluating ovarian masses in a Southeast Asian population.
Ong C; Biswas A; Choolani M; Low JJ
Singapore Med J; 2013 Mar; 54(3):136-9. PubMed ID: 23546025
[TBL] [Abstract][Full Text] [Related]
10. Preoperative detection of ovarian cancer by color Doppler ultrasonography and CA 125.
Hossain F; Karim MN; Rahman SM; Khan N; Siddiqui M; Hussain R
Bangladesh Med Res Counc Bull; 2010 Aug; 36(2):68-73. PubMed ID: 21473205
[TBL] [Abstract][Full Text] [Related]
11. [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy].
Dong L; Chang XH; Ye X; Zhu LR; Zhao Y; Tian L; Cheng HY; Li XP; Zhang H; Liao QP; Fu TY; Cheng YX; Cui H
Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):931-6. PubMed ID: 19134334
[TBL] [Abstract][Full Text] [Related]
12. Correlation of serum, urinary and salivary CA 125 levels in patients with adnexal masses.
Tay SK; Chua EK
Ann Acad Med Singap; 1994 May; 23(3):311-4. PubMed ID: 7944239
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of CA 125 in ovarian cyst fluid of patients with epithelial ovarian cancer.
Kolwijck E; Span PN; Thomas CM; Bulten J; Sweep FC; Massuger LF
Oncol Rep; 2010 Feb; 23(2):579-84. PubMed ID: 20043124
[TBL] [Abstract][Full Text] [Related]
14. A multicenter clinical trial validating the performance of HE4, CA125, risk of ovarian malignancy algorithm and risk of malignancy index.
Lycke M; Kristjansdottir B; Sundfeldt K
Gynecol Oncol; 2018 Oct; 151(1):159-165. PubMed ID: 30149898
[TBL] [Abstract][Full Text] [Related]
15. Use of serum secretory leukocyte protease inhibitor levels in patients to improve specificity of ovarian cancer diagnosis.
Tsukishiro S; Suzumori N; Nishikawa H; Arakawa A; Suzumori K
Gynecol Oncol; 2005 Feb; 96(2):516-9. PubMed ID: 15661245
[TBL] [Abstract][Full Text] [Related]
16. Serum C-reactive protein in the differential diagnosis of ovarian masses.
Hefler-Frischmuth K; Hefler LA; Heinze G; Paseka V; Grimm C; Tempfer CB
Eur J Obstet Gynecol Reprod Biol; 2009 Nov; 147(1):65-8. PubMed ID: 19619929
[TBL] [Abstract][Full Text] [Related]
17. MMP3 in Comparison to CA 125, HE4 and the ROMA Algorithm in Differentiation of Ovarian Tumors.
Cymbaluk-Ploska A; Chudecka-Glaz A; Surowiec A; Pius-Sadowska E; Machalinski B; Menkiszak J
Asian Pac J Cancer Prev; 2016; 17(5):2597-603. PubMed ID: 27268637
[TBL] [Abstract][Full Text] [Related]
18. Ovarian fibroma/fibrothecoma: retrospective cohort study shows limited value of risk of malignancy index score.
Numanoglu C; Kuru O; Sakinci M; Akbayır O; Ulker V
Aust N Z J Obstet Gynaecol; 2013 Jun; 53(3):287-92. PubMed ID: 23611791
[TBL] [Abstract][Full Text] [Related]
19. [Clinical study of autoantibody spectrum against ovarian cancer associated antigens combined with CA(125) in detecting and monitoring ovarian cancer].
Yang ZJ; Yang G; Jiang YM; Ran YL; Yang ZH; Zhang W; Zhang JQ; Pan ZM; Li L
Zhonghua Fu Chan Ke Za Zhi; 2011 Feb; 46(2):113-8. PubMed ID: 21426769
[TBL] [Abstract][Full Text] [Related]
20. Preoperative assessment of ovarian tumors by CA 125 measurement and transvaginal color Doppler ultrasound.
Kupesić S; Vujisić S; Kurjak A; Mihaljević D; Radosević S
Acta Med Croatica; 2002; 56(1):3-10. PubMed ID: 12455447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
